About Asklepios-Fachkliniken Muenchen-Gauting; Onkologie
"Bei Asklepios steht der Mensch im Mittelpunkt. Unsere Mitarbeiterinnen und Mitarbeiter behandeln in unseren Klinken und Lehrkrankenhäusern bundesweit pro Jahr mehr als zwei Millionen Patientinnen und Patienten auf höchstem medizinischen Niveau nach höchsten Qualitätsstandards. Dabei verfolgen wir stets den Anspruch, jeder Patientin und jedem Patienten eine bestmögliche Behandlung in einem jederzeit sicheren Umfeld bei gleichzeitig persönlicher Zuwendung zukommen zulassen. Ob Krankenhaus der Maximalversorgung, spezialisierte Fach- oder Rehaklinik, bei uns werden Sie von hochqualifizierten Fachkräften nach modernsten medizinischen Standards versorgt."
Clinical Trials at Asklepios-Fachkliniken Muenchen-Gauting; Onkologie
During the past decade, Asklepios-Fachkliniken Muenchen-Gauting; Onkologie conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Asklepios-Fachkliniken Muenchen-Gauting; Onkologie
According to Clinical.Site data, the most researched conditions in "Asklepios-Fachkliniken Muenchen-Gauting; Onkologie" are
"Non-Small Cell Lung Cancer" (3 trials), "Adenocarcinoma" (1 trials), "Bronchial Diseases" (1 trials), "Carcinoma" (1 trials) and "Carcinoma, Bronchogenic" (1 trials). Many other conditions were trialed in "Asklepios-Fachkliniken Muenchen-Gauting; Onkologie" in a lesser frequency.
Clinical Trials Intervention Types at Asklepios-Fachkliniken Muenchen-Gauting; Onkologie
Most popular intervention types in "Asklepios-Fachkliniken Muenchen-Gauting; Onkologie" are "Drug" (8 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (3 trials), "Docetaxel" (3 trials), "Pemetrexed" (3 trials), "Carboplatin" (2 trials) and "Cisplatin" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Asklepios-Fachkliniken Muenchen-Gauting; Onkologie
The vast majority of trials in "Asklepios-Fachkliniken Muenchen-Gauting; Onkologie" are
8 trials for "All" genders.
Clinical Trials Status at Asklepios-Fachkliniken Muenchen-Gauting; Onkologie
Currently, there are NaN active trials in "Asklepios-Fachkliniken Muenchen-Gauting; Onkologie".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Asklepios-Fachkliniken Muenchen-Gauting; Onkologie,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Asklepios-Fachkliniken Muenchen-Gauting; Onkologie, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".